← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2015Last known activity
Apr 30, 2026
Timeline
2000s
- Jun 1, 2003
Nanobiotix— Founded
Drugs by trial phase (2 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Merkel Cell
- Carcinoma, Squamous Cell
- Disease
- Liver Neoplasms
- Melanoma
- Microsatellite Instability
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
Recent trials (6)
- NCT07224152CollaboratorPhase 1/Phase 2Apr 30, 2026
- NCT04892173Lead sponsorPhase 3Jul 31, 2021
- NCT03589339Lead sponsorPhase 1/Phase 2Sep 21, 2018
- NCT02805894Lead sponsorPhase 1/Phase 2Nov 1, 2016
- NCT02721056Study directorPhase 1/Phase 2Nov 1, 2015
- NCT02721056Lead sponsorPhase 1/Phase 2Nov 1, 2015
Details
- Founded
- Paris, FR Jun 1, 2003
- Last known activity
- Apr 30, 2026